ImmunotherapyASH
Diagonal Therapeutics to Present New Preclinical Data Demonstrating Disease-Modifying Potential of Receptor Clustering Antibody Approach in HHT at EHA 2025 Congress
Clinical ResultClinical Study
17 Jun 2025
Third Harmonic Bio Announces Stockholder Approval of Plan of Liquidation and Dissolution, Updated THB335 Phase 1 Clinical Data, and Initiation of Sale of THB335
Clinical Result
Celldex Presents Data Demonstrating Profound Long Term Improvement in Angioedema in Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2025
Clinical ResultImmunotherapy
Cell TherapyAccelerated ApprovalDrug ApprovalOrphan DrugClinical Study
Syndax Presents New Revuforj® (revumenib) Data in Relapsed/Refractory mNPM1 and NUP98r Acute Leukemia from AUGMENT-101 Trial at EHA 2025
Clinical ResultFast TrackOrphan DrugDrug Approval
13 Jun 2025
12 Jun 2025
11 Jun 2025